Old Web
English
Sign In
Acemap
>
authorDetail
>
Anna Sophie Klaeschen
Anna Sophie Klaeschen
University Hospital Bonn
Ruxolitinib
CXCL10
Immunology
JAK-STAT signaling pathway
Interferon
2
Papers
33
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
JAK1/2 inhibition impairs the development and function of inflammatory dendritic epidermal cells in atopic dermatitis.
2020
The Journal of Allergy and Clinical Immunology
Anna Sophie Klaeschen
Tim Joachim Nümm
Nadine Herrmann
Nicole Leib
Laura Maintz
Takashi Sakai
Joerg Wenzel
Thomas Bieber
Show All
Source
Cite
Save
Citations (5)
JAK inhibitor ruxolitinib inhibits the expression of cytokines characteristic of cutaneous lupus erythematosus
2017
Experimental Dermatology
Anna Sophie Klaeschen
Dominik Wolf
Peter Brossart
Thomas Bieber
Joerg Wenzel
Show All
Source
Cite
Save
Citations (28)
1